These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38570137)

  • 1. Carbapenem non-susceptibility overcalling by BD phoenix NMIC-500 panel.
    Yoo IY; Ha SI; Kim SW; Kim JK; Seok HS; Park YJ
    J Infect Chemother; 2024 Apr; ():. PubMed ID: 38570137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible
    Zhang J; Jia P; Zhu Y; Zhang G; Xu Y; Yang Q
    Front Med (Lausanne); 2021; 8():643194. PubMed ID: 33937287
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of BD Phoenix and disk diffusion to broth microdilution for determining cefepime susceptibility among carbapenem-resistant Enterobacterales.
    Fouad A; Simner PJ; Nicolau DP; Asempa TE
    J Clin Microbiol; 2024 Jun; 62(6):e0152023. PubMed ID: 38712928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Shall we report the carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii strains detected by BD Phoenix system?].
    Oğünç D; Ongüt G; Ozen NS; Baysan BO; Günseren F; Dağlar D; Demirbakan H; Gültekin M
    Mikrobiyol Bul; 2010 Apr; 44(2):197-202. PubMed ID: 20549953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance evaluation of automated BD Phoenix NMIC-500 panel for carbapenemase detection in carbapenem-resistant and carbapenem-susceptible Enterobacterales.
    Cho H; Kim JO; Choi JE; Lee H; Heo W; Cha YJ; Yoo IY; Park YJ
    J Microbiol Methods; 2020 Oct; 177():106042. PubMed ID: 32890572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway.
    Kulah C; Aktas E; Comert F; Ozlu N; Akyar I; Ankarali H
    BMC Infect Dis; 2009 Mar; 9():30. PubMed ID: 19291298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the BD Phoenix automated system for determining antimicrobial susceptibility against carbapenem-resistant Enterobacteriaceae compared with broth microdilution.
    Haffler ZJ; Kulengowski B; Ribes JA; Burgess DS
    Int J Antimicrob Agents; 2019 Aug; 54(2):249-254. PubMed ID: 31071467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of susceptibility of Pseudomonas aeruginosa clinical isolates to carbapenem antibiotics in our hospital].
    Kakeya H; Yamada K; Nakaie K; Takizawa E; Okada Y; Fujita A; Nakamura Y; Abe J; Hirose A; Kaneko Y; Hino M
    Jpn J Antibiot; 2014 Aug; 67(4):241-8. PubMed ID: 25420320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints.
    Gupta V; Yu KC; Pogue JM; Watts JA; Clancy CJ
    Microbiol Spectr; 2022 Jun; 10(3):e0115822. PubMed ID: 35638777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Evaluation of the Newly Developed BD Phoenix NMIC-500 Panel Using Clinical Isolates of Gram-Negative Bacilli.
    Park BY; Mourad D; Hong JS; Yoon EJ; Kim D; Lee H; Jeong SH
    Ann Lab Med; 2019 Sep; 39(5):470-477. PubMed ID: 31037866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.
    Tenover FC; Kalsi RK; Williams PP; Carey RB; Stocker S; Lonsway D; Rasheed JK; Biddle JW; McGowan JE; Hanna B
    Emerg Infect Dis; 2006 Aug; 12(8):1209-13. PubMed ID: 16965699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of BD Phoenix CPO Detect Panels for Detection and Classification of Carbapenemase-Producing Gram-Negative Bacteria.
    Murata M; Kosai K; Akamatsu N; Matsuyama Y; Oda M; Wakamatsu A; Izumikawa K; Mukae H; Yanagihara K
    Microbiol Spectr; 2023 Jun; 11(3):e0089723. PubMed ID: 37162344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of Seven Tigecycline Susceptibility Testing Methods for Carbapenem-Resistant
    Li H; Zhou M; Chen X; Zhang Y; Jian Z; Yan Q; Liu WE
    Infect Drug Resist; 2021; 14():1511-1516. PubMed ID: 33907429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.
    Endimiani A; Perez F; Bajaksouzian S; Windau AR; Good CE; Choudhary Y; Hujer AM; Bethel CR; Bonomo RA; Jacobs MR
    J Clin Microbiol; 2010 Dec; 48(12):4417-25. PubMed ID: 20881179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three different methods for susceptibility testing of gentamicin in carbapenem resistant Enterobacterales.
    Cayci YT; Ulker KH; Birinci A
    Infez Med; 2021; 29(4):568-573. PubMed ID: 35146366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-susceptibilities to antibiotics against important Gram-negative bacteria, and imipenem-relebactam, meropenem-vaborbactam against carbapenem non-susceptible Enterobacterales and Pseudomonas aeruginosa isolates implicated in complicated intra-abdominal and urinary tract infections in Taiwan, 2019.
    Jean SS; Lu MC; Ho MW; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2022 Mar; 59(3):106521. PubMed ID: 35066144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance.
    Ikenoue C; Matsui M; Inamine Y; Yoneoka D; Sugai M; Suzuki S;
    BMC Infect Dis; 2024 Feb; 24(1):209. PubMed ID: 38360618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
    Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
    Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the BD Phoenix M50 Automated Microbiology System for Antimicrobial Susceptibility Testing with Clinical Isolates in Korea.
    Hong JS; Kim D; Kang DY; Park BY; Yang S; Yoon EJ; Lee H; Jeong SH
    Microb Drug Resist; 2019 Oct; 25(8):1142-1148. PubMed ID: 31161952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.